APOTEX-MYCOPHENOLATE mycophenolate mofetil 250 mg capsule blister pack

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
29-11-2017

Bahan aktif:

mycophenolate mofetil, Quantity: 250 mg

Boleh didapati daripada:

Arrotex Pharmaceuticals Pty Ltd

INN (Nama Antarabangsa):

Mycophenolate mofetil

Borang farmaseutikal:

Capsule

Komposisi:

Excipient Ingredients: croscarmellose sodium; indigo carmine; Gelatin; titanium dioxide; purified water; iron oxide red; magnesium stearate; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

Laluan pentadbiran:

Oral

Unit dalam pakej:

100 capsules, 300 capsules

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

Mycophenolate mofetil is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.,Mycophenolate mofetil is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Ringkasan produk:

Visual Identification: Opaque blue cap and opaque pink body in Size 1 capsule containing white to off white powder. "M250" and "APO" are imprinted on capsules in black ink.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Status kebenaran:

Licence status A

Tarikh kebenaran:

2011-11-08